PHASE 01
Source-backedInternal foundation
- Launch a general internal assistant
- Measure employee adoption and collect workflow demand
Exit gate: Usage, security, and support model understood
Documented implementation, not a PilotPlan customer story
A documented enterprise AI adoption case covering internal assistants, custom GPTs, clinical analysis support, policy search, and contract summarization.
Moderna wanted to increase employee capacity across scientific, clinical, legal, and business work without relying on a single central team to build every AI use case.
Reported by OpenAI and the featured company. Not independently verified by PilotPlan.
A simplified logical architecture reconstructed from the public case study. It is not claimed to be the company's private network diagram.
mChat, ChatGPT Enterprise, custom GPTs, Dose ID, Policy Bot, and Contract Companion are documented. The shared governance layer and connection pattern are inferred because detailed internal architecture is not public.
A practical sequence based on documented milestones where available, with inferred and recommended steps clearly marked.
PHASE 01
Source-backedExit gate: Usage, security, and support model understood
PHASE 02
Source-backedExit gate: Platform and governance decision
PHASE 03
InferredExit gate: Owner, data class, and review level assigned to every GPT
PHASE 04
RecommendedExit gate: Domain validation and accountable sign-off
What the implementation needs, and how confidently the public evidence supports each element.
mChat internal assistant built with the OpenAI API
ChatGPT Enterprise and employee-created GPTs
Dose ID clinical analysis pilot, Policy Bot, and Contract Companion
Central catalog, approval tiers, and lifecycle controls for internal GPTs
The accountable roles needed to build, approve, and operate this kind of system.
Central AI platform team provides the enterprise service and builder enablement
Business and scientific teams create domain-specific GPTs
Clinical, legal, privacy, and security reviewers approve high-impact use
Controls explicitly documented or required to make the reconstructed implementation safe enough to operate.
Classify use cases by impact, data sensitivity, and required review
Require citations and human verification for clinical and legal outputs
Maintain a registry with owner, purpose, data sources, evaluation, and retirement date
What should happen when the model, integration, downstream system, or generated output is wrong.
Outdated policy answer: retrieve from governed sources and show effective dates
Clinical reasoning error: restrict output to decision support and require qualified review
Unowned GPT sprawl: expire or quarantine tools without an active owner and evaluation
Published measures are separated from the additional metrics a responsible implementation should track.
Weekly active users, conversations, and GPT builders
Task completion time and correction rate by workflow
Source coverage, reviewer agreement, and safety incidents for high-impact uses
Public case studies rarely disclose full architecture, permissions, evaluation data, cost, or failure rates. These gaps must be validated before treating this as an implementation specification.
PilotPlan summarized the implementation and added practical analysis. Read the original vendor-produced case study before relying on any claim.
Moderna enterprise AI case study by OpenAIIt first built an internal assistant with the OpenAI API, then compared available enterprise tools through user testing before broad deployment.
The source describes clinical data analysis support, policy questions, contract summaries, and many employee-created GPTs across business functions.
Treat sensitive AI outputs as decision support, preserve source visibility, and require qualified humans to validate high-impact work.
Describe the challenge, constraints, current stack, budget, and timeline. PilotPlan researches the options and assembles a sourced implementation plan.